74 filings
Page 3 of 4
CORRESP
1fhuou5m7pvi fcym3gr
1 Dec 21
Correspondence with SEC
12:00am
UPLOAD
qugctl17x
24 Nov 21
Letter from SEC
12:00am
4
fa3o5pkfwu20cthn1zg
18 Nov 21
Coeptis Therapeutics / David Mehalick ownership change
2:00pm
1-A
9nnqt1
18 Nov 21
Offering $12M in Equity
12:44pm
D/A
yvszq 2smln
12 Oct 21
$9M in equity, sold $5.52M, 42 investors
7:52am
8-K
pwozhns
1 Oct 21
Termination of a Material Definitive Agreement
12:00am
8-K
d0m1hp9y
27 Aug 21
Termination of a Material Definitive Agreement
12:00am
8-K
m47pg145dmrwyy7 sjin
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm
D/A
j06vn3 wrv
28 Jul 21
$6M in equity, sold $5.21M, 39 investors
11:34am
8-K
6c8m7ng ezacv
13 Jul 21
New Corporate Name and Updated Stock Ticker Symbol Highlight Company’s Brand Transformation
2:36pm
10-KT
4m5y1
11 May 21
Annual report (with FYE transition)
4:48pm
8-K
n3gaete7ftdiy oe
11 May 21
Entry into a Material Definitive Agreement
2:20pm
8-K/A
99a7whni8
10 May 21
Completion of Acquisition or Disposition of Assets
7:47am
8-K
8xhlk5wnw1g5a 52qpgf
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:19pm
D
ysweun
24 Mar 21
$6M in equity, sold $171K, 2 investors
11:21am
D
v7bmj
25 Feb 21
$0 in equity, 81 investors
12:03pm